Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSGS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02921789
What this trial is testing

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationPrimary Focal Segmental Glomerulosclerosis (FSGS)
Astellas Pharma Global Development, Inc. 67
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Large-scale testing (Phase 3)Study completedNCT00135811
What this trial is testing

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Who this might be right for
Glomerulosclerosis, Focal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 192
Not applicableEnded earlyNCT01451489
What this trial is testing

The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis

Who this might be right for
FSGS
Nanjing University School of Medicine 70
Not applicableLooking for participantsNCT05583942
What this trial is testing

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 10
Not applicableStudy completedNCT00001393
What this trial is testing

Genetic Markers for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Testing effectiveness (Phase 2)Looking for participantsNCT07268638
What this trial is testing

Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Akebia Therapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT06090227
What this trial is testing

AMPK-activation by Metformin in FSGS: AMP-FSGS

Who this might be right for
Focal Segmental Glomerulosclerosis
Yale University 30
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Testing effectiveness (Phase 2)Study completedNCT01573533
What this trial is testing

A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Mayo Clinic 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06635720
What this trial is testing

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome+1 more
The Hospital for Sick Children 50
Testing effectiveness (Phase 2)Study completedNCT03422510
What this trial is testing

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Complexa, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00814255
What this trial is testing

Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

Who this might be right for
Focal Segmental Glomerulosclerosis
NYU Langone Health 32
Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Large-scale testing (Phase 3)Study completedNCT00065611
What this trial is testing

Steroid Treatment for Kidney Disease

Who this might be right for
NephrosisFocal Lipoid Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8
Early research (Phase 1)WithdrawnNCT00816504
What this trial is testing

Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

Who this might be right for
Focal Segmental Glomerulosclerosis
Northwell Health
Early research (Phase 1)Study completedNCT05562362
What this trial is testing

Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

Who this might be right for
Healthy Subjects
Travere Therapeutics, Inc. 47
Not applicableLooking for participantsNCT04065438
What this trial is testing

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Who this might be right for
Focal Segmental Glomerulosclerosis
Kaneka Medical America LLC 35
Next Page